Ipilimumab/Nivolumab/PembrolizumabPure red cell aplasia, bell's palsy and immune thrombocytopenia

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-023-51530-2
中图分类号
学科分类号
摘要
引用
收藏
页码:225 / 225
相关论文
共 50 条
  • [23] Bell's palsy during rechallenge of immune checkpoint inhibitor
    Takemura, Kohji
    Yamanaka, Taro
    Hayashida, Michikata
    Kizawa, Rika
    Yamaguchi, Takeshi
    Tanabe, Yuko
    Sakaguchi, Kazushige
    Suyama, Koichi
    Urakami, Shinji
    Miura, Yuji
    IJU CASE REPORTS, 2023, 6 (02) : 144 - 146
  • [24] Acquired pure red cell aplasia: unraveling the immune pathogenesis
    Liu Mengyuan
    Zhang Tian
    Dong Xifeng
    Wang Huaquan
    生物组学研究杂志(英文), 2023, 06 (04)
  • [25] A case of pure red cell aplasia during nivolumab therapy for cardiac metastatic melanoma
    Yuki, Akihiko
    Takenouchi, Tatsuya
    Takatsuka, Sumiko
    Ishiguro, Takuro
    MELANOMA RESEARCH, 2017, 27 (06) : 635 - 637
  • [26] Follicular dendritic cell sarcoma and its response to immune checkpoint inhibitors nivolumab and ipilimumab
    Lee, Mee-young
    Bernabe-Ramirez, Carolina
    Ramirez, Daniel C.
    Maki, Robert G.
    BMJ CASE REPORTS, 2020, 13 (04)
  • [27] Severe immune thrombocytopenia induced by nivolumab in a patient with metastatic renal cell carcinoma
    Hata, Shinro
    Abe, Satoki
    UROLOGY CASE REPORTS, 2020, 32
  • [28] Aplastic anemia, amegakaryocytic thrombocytopenia and red cell aplasia with CLL: Responses to Rituxan.
    Bharwani, L
    Rice, L
    BLOOD, 2002, 100 (11) : 362B - 362B
  • [30] Lymphocyte subsets in Bell's palsy:: Immune pathogenesis and outcome prediction
    Tekgul, H
    Polat, M
    Serdaroglu, G
    Ikizoglu, T
    Yalaz, M
    Kutukculer, N
    Gökben, S
    PEDIATRIC NEUROLOGY, 2004, 31 (04) : 258 - 260